`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 13-391 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`AIMNEAL PHARMACEUTICALS, LLC
`and PAR PHARMACEUTICAL, INC.,
`
`Defendants.
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 14-3235 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`AMNEAL PHARMACEUTICALS,
`LLC,
`
`Defendant.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`AMNEAL PHARMACEUTICALS,
`LLC,
`
`Defendant.
`
`Civil Action No. 15-1043 (ES)(JAD)
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 2 of 8 PageID: 1750
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 14-5139 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`PAR PHARMACEUTICAL, INC.,
`
`Defendant.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`PAR PHARMACEUTICAL, INC.,
`
`Defendant.
`
`Civil Action No. 14-6150 (ES)(JAD)
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 15-173 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`PAR PHARMACEUTICAL, INC.,
`
`Defendant.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 3 of 8 PageID: 1751
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 14-4467 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`RANBAXY LABORATORIES
`LIMITED AND RANBAXY INC.,
`
`Defendants.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`RANBAXY LABORATORIES
`LIMITED AND RANBAXY INC.,
`
`Defendants.
`
`Civil Action No. 14-6151 (ES)(JAD)
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Civil Action No. 15-187 (ES)(JAD)
`
`Plaintiff,
`
`V.
`
`RANBAXY LABORATORIES
`LIMITED AND RANBAXY INC.,
`
`Defendants.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 4 of 8 PageID: 1752
`
`Civil Action No. 14-7757 (ES)(JAD)
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS
`IRELAND LIMITED,
`
`Plaintiffs,
`
`V.
`
`WATSON LABORATORIES, INC.,
`
`Defendant.
`
`CONSOLIDATION STIPULATION AND ORDER
`
`WHEREAS, Plaintiff Jazz Pharmaceuticals, Inc. (“Jazz”) initiated Civil Action
`
`Nos. 14-323 5 (ES)(JAD) and 15-1043 (ES)(JAD), alleging infringement of United States
`
`Patent Nos. 8,589,182, 8,731,963, 8,772,306, and 8,859,619 by Defendant Amneal
`
`Pharmaceuticals, LLC ‘S (“Amneal”) submission of Abbreviated New Drug Application
`
`(“ANDA”) No. 203631 to the U.S. Food and Drug Administration for approval to market a
`
`500 mg/mi sodium oxybate oral solution;
`
`WFIEREAS, Jazz initiated Civil Action Nos. 14-5139 (ES)(JAD), 14-6150
`
`(ES)(JAD), and 15-173 (ES)(JAD) alleging infringement of United States Patent Nos.
`
`8,731,963, 8,772,306, and 8,859,619 by Defendant Par Pharmaceutical, Inc.’s (“Par”)
`
`submission of ANDA No. 205403 to the U.S. Food and Drug Administration for approval to
`
`market a 500 mg/mi sodium oxybate oral solution;
`
`WIIEREAS, Jazz initiated Civil Action Nos. 14-4467 (ES)(JAD), 14-6151
`
`(ES)(JAD), and 15-187 (ES)(JAD) alleging infringement of United States Patent Nos.
`
`6,472,431, 6,780,889, 7,262,219, 7,851,506, 8,263,650, 8,324,275, 8,461,203, 7,668,730,
`
`7,765,106, 7,765,107, 7,895,059, 8,457,988, 8589,182, 8,731,963, 8,772,306, and
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 5 of 8 PageID: 1753
`
`8,859,619 by Defendant Ranbaxy Laboratories Limited and Ranbaxy, Inc.’s (“Ranbaxy”)
`
`submission of ANDA No. 203351 to the U.S. Food and Drug Administration for approval to
`
`market a 500 mg/mi sodium oxybate oral solution;
`
`WHEREAS, Jazz initiated Civil Action No, 14-775 7 (ES)(JAD), alleging
`
`infringement of United States Patent Nos. 6,472,431, 6,780,889, 7,262,219, 7,851,506,
`
`8,263,650, 8,324,275, 8,461,203, 7,668,730, 7,765,106, 7,765,107, 7,895,059, 8,457,988,
`
`8589,182, 8,731,963, and 8,772,306 by Defendant Watson Laboratories, Inc.’s
`
`(“Watson”) submission of ANDA No. 204952 to the U.S. Food and Drug Administration
`
`for approval to market a 500 mglm[ sodium oxybate oral solution;
`
`WHEREAS, these causes of action are substantially related to the litigation initiated
`
`by Jazz captioned Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC and Par
`
`Pharmaceutical, Inc., Civil Action No. 13-391 (ES)(JAD), which is also before this Court
`
`and concerns United States Patent Nos. 6,472,431, 6,780,889, 7,262,219, 7,851,506,
`
`8,263,650, 8,324,275, 8,461,203, 7,668,730, 7,765,106, 7,765,107, 7,895,059, 8,457,988,
`
`and 8,589,182;
`
`WHEREAS, the parties have agreed to the consolidation of these actions;
`
`WHEREAS, good cause exists to consolidate these actions with Civil Action No.
`
`13-391;
`
`WHEREFORE, Jazz, Amneal, Par, Ranbaxy and Watson, by their attorneys,
`
`respectfully request that this Court consolidate Civil Action Nos. 14-3235, 15-1043, 14-
`
`5139, 14-6150, 15-173, 14-4467, 14-6151, 15-187, 14-7757, with Civil Action No. 13-
`
`391 and that all of the papers be maintained in Civil Action No. 13-391.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 6 of 8 PageID: 1754
`
`Dated: April 20, 2015
`
`Respectfully submitted,
`
`By:
`
`sI Charles M. Lizza
`Charles M. Lizza
`William C. Baton
`SAUL EWING LLP
`One Riverfront Plaza, Suite 1520
`Newark, NJ 07102-5426
`(973) 286-6700
`clizza@saul.com
`
`A ttorneysfor Plaintff
`Jazz Pharmaceuticals, Inc.
`
`By:
`
`s/ Paul H. Kochanski
`Paul H. Kochanski
`LERNER, DAVID, LITTENBERG,
`KRUMHOLZ & MENTLK, LLP
`600 South Avenue West
`Westfield, NJ 07090
`(908) 654-5000
`pkochanski@ldIkm.com
`
`Attorneysfor Defendant
`Amneal Pharmaceuticals, LLC
`
`OfCounsel:
`
`OfCounsel:
`
`F. Dominic Cerrito
`Eric C. Stops
`Gabriel P. Brier
`QuuN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22’’ Floor
`New York, New York 10010
`(212) 203-7625
`
`By:
`
`Richard G. Greco
`RICHARD G. GRECO PC
`90 State Street, Suite 700
`Albany, New York 12207
`(212) 203-7625
`
`SI Sean R. Kelly
`Sean R. Kelly
`Katherine A. Escanlar
`SABER LLC
`18 Columbia Turnpike
`Suite 200
`Florham Park, NJ 07932
`(973) 645-4801
`
`Attorneysfor Defendant
`Par Pharmaceutical, Inc.
`
`H. Keeto Sabharwal
`Dennies Varughese
`Deborah Sterling
`STERNE, KESSLER, GOLDSTEIN & Fox
`PLLC
`1100 New York Ave., N.W., Suite
`800
`Washington, DC 20005-3934
`(202) 7728511
`
`By:
`
`s/ Karen A. Confoy
`Karen A. Confoy
`Christopher R. Kinkade
`Steven 3. Daroci
`Fox Rothschild LLP
`Princeton Pike Corporate Center
`997 Lenox Drive, Building 3
`Lawrenceville, NJ 08648-2311
`(609) 896-3600
`
`Attorneysfor Defendant
`Ranhaxy Laboratories Limited and
`Ranbaxy Inc.
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 7 of 8 PageID: 1755
`
`OfCounsel:
`
`OfCounsel:
`
`Richard J. Berman
`Janine A. Carlan
`Aziz Burgy
`Bradford C. Frese
`ARENT Fox LLP
`1717 K Street NW
`Washington, DC 20006-5344
`(202) 857-6000
`
`William R. Zimmerman
`KNOBBE, MARTENS, OLSON & BEAR,
`LLP
`1717 Pennsylvania Avenue, N.W.,
`Suite 900
`Washington, D.C. 20006
`(202) 640-6400
`
`Carol Pitzel Cruz
`Christie R.W. Matthaei
`KNOBBE, MARTENS, OLSON & BEAR,
`LLP
`925 Fourth Avenue, Suite 2500
`Seattle, WA 98104
`(206) 405-2000
`
`By:
`
`sI Liza M. Walsh
`Liza M. Walsh
`Tricia O’Reilly
`Katelyn O’Reilly
`CONNELL FOLEY LLP
`85 Livingston Avenue
`Roseland, New Jersey 07068
`(973) 535-0500
`
`Attorneysfor Defendant
`Watson Laboratories, Inc.
`
`OfCounsel:
`
`Gary E. Hood
`Mark T. Deming
`POLSINELLI PC
`161 North Clark Street, Suite 4200
`Chicago, Illinois 60601
`(312) 819-1900
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 125 Filed 04/21/15 Page 8 of 8 PageID: 1756
`
`ITISonthisLdayofffl4i 2015*
`
`Hon. 3 sep11 A. Dickson, U.S.M.J.
`
`cc: Hon. Esther Salas, U.S.D.J.
`
`*
`
`ORDERED that Civil Action Nos. 14-3235, 14-4467, 14-5139, 14-6150, 14-6151, 14-7757, 15-173,
`
`15-187 and 15-1043 are hereby consolidated with Civil Action No. 13-391; and it is further
`
`ORDERED that the older action, Civil Action No. 13-39 1, shall serve as the lead case; and it is further
`
`ORDERED that all papers filed in this consolidated matters shall be filed under Civil Action No.
`
`13-391.
`
`